Portal de Periódicos da CAPES

Terbinafine in the treatment of cutaneous leishmaniasis: a pilot study

1997; Wiley; Volume: 36; Issue: 1 Linguagem: Inglês

10.1046/j.1365-4362.1997.00021.x

1365-4632

Khalid Bahamdan, Talal M. Tallab, Hanan Johargi, Mohamed Mazen Nourad, Karam Ibrahim, Abdulk Hameed El Sherbini, Eman M. Karkashan, Ashok Kumar Khare, Mustafa M. Nauri,

Beetle Biology and Toxicology Studies

International Journal of DermatologyVolume 36, Issue 1 p. 59-60 Terbinafine in the treatment of cutaneous leishmaniasis: a pilot study Khalid A. Bahamdan MD, Khalid A. Bahamdan MD King Saud University, College of Medicine, Abha Bmach; and Asir Central Hospital, Abha, Saudi ArabiaSearch for more papers by this authorTalal M. Tallab MD, FRCP(C), Corresponding Author Talal M. Tallab MD, FRCP(C) King Saud University, College of Medicine, Abha Bmach; and Asir Central Hospital, Abha, Saudi ArabiaTalal M. Tallab, MD, FRCP(C), King Saud University, College of Medicine, Abha Brnach, PO Box 641, Abha, Saudi ArabiaSearch for more papers by this authorHanan Johargi MD, Hanan Johargi MD King Saud University, College of Medicine, Abha Bmach; and Asir Central Hospital, Abha, Saudi ArabiaSearch for more papers by this authorMohamed Mazen Nourad MD, PhD (UK), Mohamed Mazen Nourad MD, PhD (UK) King Saud University, College of Medicine, Abha Bmach; and Asir Central Hospital, Abha, Saudi ArabiaSearch for more papers by this authorKaram Ibrahim MD, CES (France), Karam Ibrahim MD, CES (France) King Saud University, College of Medicine, Abha Bmach; and Asir Central Hospital, Abha, Saudi ArabiaSearch for more papers by this authorAbdulk Hameed El Sherbini MD, Abdulk Hameed El Sherbini MD King Saud University, College of Medicine, Abha Bmach; and Asir Central Hospital, Abha, Saudi ArabiaSearch for more papers by this authorEman Karkashan MD, Eman Karkashan MD King Saud University, College of Medicine, Abha Bmach; and Asir Central Hospital, Abha, Saudi ArabiaSearch for more papers by this authorAshok K. Khare MD, Ashok K. Khare MD King Saud University, College of Medicine, Abha Bmach; and Asir Central Hospital, Abha, Saudi ArabiaSearch for more papers by this authorMustafa M. Nauri MD, Mustafa M. Nauri MD King Saud University, College of Medicine, Abha Bmach; and Asir Central Hospital, Abha, Saudi ArabiaSearch for more papers by this author Khalid A. Bahamdan MD, Khalid A. Bahamdan MD King Saud University, College of Medicine, Abha Bmach; and Asir Central Hospital, Abha, Saudi ArabiaSearch for more papers by this authorTalal M. Tallab MD, FRCP(C), Corresponding Author Talal M. Tallab MD, FRCP(C) King Saud University, College of Medicine, Abha Bmach; and Asir Central Hospital, Abha, Saudi ArabiaTalal M. Tallab, MD, FRCP(C), King Saud University, College of Medicine, Abha Brnach, PO Box 641, Abha, Saudi ArabiaSearch for more papers by this authorHanan Johargi MD, Hanan Johargi MD King Saud University, College of Medicine, Abha Bmach; and Asir Central Hospital, Abha, Saudi ArabiaSearch for more papers by this authorMohamed Mazen Nourad MD, PhD (UK), Mohamed Mazen Nourad MD, PhD (UK) King Saud University, College of Medicine, Abha Bmach; and Asir Central Hospital, Abha, Saudi ArabiaSearch for more papers by this authorKaram Ibrahim MD, CES (France), Karam Ibrahim MD, CES (France) King Saud University, College of Medicine, Abha Bmach; and Asir Central Hospital, Abha, Saudi ArabiaSearch for more papers by this authorAbdulk Hameed El Sherbini MD, Abdulk Hameed El Sherbini MD King Saud University, College of Medicine, Abha Bmach; and Asir Central Hospital, Abha, Saudi ArabiaSearch for more papers by this authorEman Karkashan MD, Eman Karkashan MD King Saud University, College of Medicine, Abha Bmach; and Asir Central Hospital, Abha, Saudi ArabiaSearch for more papers by this authorAshok K. Khare MD, Ashok K. Khare MD King Saud University, College of Medicine, Abha Bmach; and Asir Central Hospital, Abha, Saudi ArabiaSearch for more papers by this authorMustafa M. Nauri MD, Mustafa M. Nauri MD King Saud University, College of Medicine, Abha Bmach; and Asir Central Hospital, Abha, Saudi ArabiaSearch for more papers by this author First published: 28 June 2008 https://doi.org/10.1046/j.1365-4362.1997.00021.xCitations: 23AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 Urcuyo, FC, Zaias, N. Oral ketoconazole in the treatment of cutaneous leishmaniasis. Int J Dermatol 1982; 21: 414– 415. 2 Weinrauch, L, Livshin, R, El-On, J. Efficacy of ketoconazole in cutaneous leishmaniasis. Arch Dermatol Res 1983; 275: 353– 354. 3 Alsaleh, Q, Dvorak, R, Nanda, A. Ketoconazole in the treatment of cutaneous leishmaniasis. Int J Dermatol 1991; 34: 495– 497. 4 Alfouzan, A, Asaleh, Q, Najem, N, et al. Cutaneous leishmaniasis in Kuwait: clinical experience with itraconazole. Int J Dermatol 1991; 30: 519– 521. 5 Dogra, J, Anega, N, Lal, B, et al. Cutaneous leishmaniasis to India: clinical experience with itraconazole (R51 211 Janssen). Int J Dermatol 1990; 29: 661– 662. 6 Enden, EV, Gomple, A, Stevens, A, et al. Treatment of cutaneous leishmaniasis with oral itraconazole. Int J Dermatol 1994; 33: 285– 286. 7 Beach, DH, Holtz, GG, Anchlwe, GE. Lipid of leishmania promastigotes. J Parasitol 1979; 65: 203– 216. 8 Ryder, NS, Mieth, H. Allylamine antifungal drugs. Curr Trop MedI My col 1992; 47: 158– 188. 9 Ryder, NS. Terbinafine: mode of action and properties of the squalene epoxidase inhibitor. Br J Dermatol 1992; 126 (Suppl. 39): 27. 10 Ottervanger, JP, Stroker, BH. Loss of taste and Terbinafine. Lancet 1992; 340 (8821): 728. 11 Lowe, G, Geen, C. Jennings R Hepatitis associated with terbinafine treatment. BMJ 1993; 306 (6872): 248. 12 McGregor, JM, Rustin, MH. Terbinafine and erythema multiforme. Br J Dermatol 1994; 131: 587– 588. 13 Carstens, J, Wendelboe, P, Sogaard, H, et al. Toxic epidermal necrolysis follow therapy with terbinafine. Acta Derm Venereol (Stockh) 1994; 74: 391– 392. 14 Kovacs, MJ, Al-shammari, S, Guenthor, L, et al. Neurotropenia and pancytopenia associated with terbinafine. J Am Acad Dermatol 1994; 31: 806. 15 Goad, LJ, Hole, GG, Reach, DH. Effect of allylamine antifungal drug SF86-327 on the growth and sterol synthesis of leishmania mexicana promastigtes. Biochem Pharmacol 1985; 34: 3785– 3788. 16 Maldonado, RA, Molina, J, Payares, G, et al. Experimental chemotherapy with combination of ergosterol biosynthesis inhibitors in murine models of Chaga's disease. Antimicrob Agents Chemother 1993; 37: 1353– 1359. 17 Al-zahrani, MA, Peters, W, Evans, A, et al. Leishmania infecting man and wild animals in Saudi Arabia. 6. Cutaneous leishmaniasis of man in the south-west. Trans Soc Trop Med Hyg 1989; 83: 621– 628. Citing Literature Volume36, Issue1January 1997Pages 59-60 ReferencesRelatedInformation